Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19

• Main Authors: Xiaoyan Liu (Author), Zhe Li (Author), Shuai Liu (Author), Jing Sun (Author), Zhanghua Chen (Author), Min Jiang (Author), Qingling Zhang (Author), Yinghua Wei (Author), Xin Wang (Author), Yi-You Huang (Author), Yinyi Shi (Author), Yanhui Xu (Author), Huifang Xian (Author), Fan Bai (Author), Changxing Ou (Author), Bei Xiong (Author), Andrew M. Lew (Author), Jun Cui (Author), Rongli Fang (Author), Hui Huang (Author), Jincun Zhao (Author), Xuechuan Hong (Author), Yuxia Zhang (Author), Fuling Zhou (Author), Hai-Bin Luo (Author)
• Format: Book
• Published: Elsevier, 2020-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause acute respiratory distress syndrome, hypercoagulability, hypertension, and multiorgan dysfunction. Effective antivirals with safe clinical profile are urgently needed to improve the overall prognosis. In an analysis of...